Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Sheila L. Stadler"'
Autor:
Cari R. Friesleben, Stephanie M. Campbell, Jessica M. Stine, Jennifer J. Schimmer, Kari L. Olson, Jessica Angleson, Sheila L. Stadler
Publikováno v:
Journal of the American Pharmacists Association. 62:604-611
OBJECTIVE This study aimed to compare lipid and blood pressure (BP) control before and after implementing a certified pharmacy technician (CPhT) protocol that optimized electronic health record (EHR) capabilities and shifted work from clinical pharma
Publikováno v:
Annals of Pharmacotherapy. 51:140-145
Background: Against-label prescribing of statins with interacting drugs, such as cyclosporine, represents an important patient safety concern. Objective: To implement and evaluate the effectiveness of a clinical pharmacist patient-safety initiative t
Autor:
Sheila L, Stadler, Thomas J, Cook
Publikováno v:
The American journal of managed care. 23
In patients with hypercholesterolemia who have atherosclerotic cardiovascular disease and/or familial hypercholesterolemia, a new class of drugs may be helpful in reducing serum levels of low-density lipoprotein cholesterol (LDL-C) beyond maximally t
Autor:
Michele Wood, Kari L. Olson, Anne M. Denham, Sheila L. Stadler, Roseanne Hornak, Leslie K. Ruppe, Thomas Delate
Publikováno v:
Pharmacy Practice
Pharmacy Practice (Granada), Volume: 17, Issue: 2, Article number: 1402, Published: 18 NOV 2019
Pharmacy Practice, Vol 17, Iss 2, p 1402 (2019)
Pharmacy Practice (Granada) v.17 n.2 2019
SciELO España. Revistas Científicas Españolas de Ciencias de la Salud
instname
Pharmacy Practice (Granada), Volume: 17, Issue: 2, Article number: 1402, Published: 18 NOV 2019
Pharmacy Practice, Vol 17, Iss 2, p 1402 (2019)
Pharmacy Practice (Granada) v.17 n.2 2019
SciELO España. Revistas Científicas Españolas de Ciencias de la Salud
instname
Background: High intensity statin therapy (HIST) is the gold standard therapy for decreasing the risk of recurrent atherosclerotic cardiovascular disease (ASCVD); however, little is known about the use of HIST in older adults with ASCVD. Objectives:
Autor:
Kari L. Olson, Leslie K. Ruppe, Elizabeth C. Cannon, Sarah D. Sutton, Deanna Kurz, Sheila L. Stadler, Emily Zadvorny
Publikováno v:
American Journal of Pharmaceutical Education. 83:6759
Objective. To assess the value of an advanced pharmacy practice experience in which students engaged in population health management (PHM) activities for a managed care setting. Methods. Students were provided with a list of patients, trained on the
Publikováno v:
American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists. 73(18)
Purpose Prescribing practices within a clinical pharmacy cardiac risk service (CPCRS) and their impact on treatment outcomes in patients with atherosclerotic cardiovascular disease (ASCVD) are described. Summary National healthcare reforms have incre
Publikováno v:
Journal of Clinical Lipidology. 4:298-304
Patients with chronic kidney disease (CKD) are at significant risk for cardiovascular disease (CVD). The National Kidney Foundation developed clinical practice guidelines (Kidney Disease Outcomes Quality Initiative) for targeting low-density lipoprot
Publikováno v:
Journal of Clinical Lipidology. 9:436-437